Accredo wins Flolan agreement

Article

Accredo Health Group, a subsidiary of Medco, won a five-yearcontract as the sole specialty pharmacy for Flolan (epoprostenolsodium, Myogen) for pulmonary arterial hypertension (PAH). Terms ofthe deal were not announced.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.